SequelSEC

ACADIA PHARMACEUTICALS INC ACAD

Pharmaceutical Preparations · CIK 0001070494 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$1.14B
Fiscal year ended 2026-06-30
Operating income
$86.37M
Fiscal year ended 2026-06-30
Free cash flow
$145.62M
Fiscal year ended 2026-06-30

ACADIA PHARMACEUTICALS INC (ACAD) reported revenue of $1.14B and net income of $380.48M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from ACADIA PHARMACEUTICALS INC’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Pharmaceutical Preparations.

Income

ACADIA PHARMACEUTICALS INC income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$1.14B
Cost of revenue$100.98M
Gross profit$1.04B
Operating income$86.37M
Net income$380.48M
Research & development$331.01M
Weighted-average diluted sharesUnavailable
Pretax income$121.37M
Income tax expense-$259.12M
Diluted EPSUnavailable
Selling, general & administrative$620.29M
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

ACADIA PHARMACEUTICALS INC balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$384.98M
Total assets$1.74B
Current assets$1.22B
Total liabilities$436.29M
Current liabilities$361.44M
Total equity incl. NCI$1.31B
Temporary (mezzanine) equityUnavailable
Inventory$108.67M
Accounts receivable$150.64M
GoodwillUnavailable
Long-term debtUnavailable
Accounts payable$44.57M

Cash flow

ACADIA PHARMACEUTICALS INC cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow$160.32M
Capital expenditures$14.69M
Investing cash flow-$77.47M
Financing cash flow$46.81M
Net change in cash$129.72M
Stock-based compensation$58.05M
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortizationUnavailable

Derived

ACADIA PHARMACEUTICALS INC derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flow$145.62M
Gross margin91.1%
Operating margin7.6%
FCF margin12.8%
SBC / revenue5.1%
Current ratio3.39x
Revenue YoY growth11.8%
Net margin33.4%
R&D / revenue29.1%
CapEx / revenue1.3%
Long-term debt / equityUnavailable
Effective tax rate-213.5%

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open ACAD in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-05View SEC filing
10-Q · Filed 2026-05-07View SEC filing
10-K · Filed 2026-02-26View SEC filing
10-Q · Filed 2025-11-06View SEC filing
10-Q · Filed 2025-08-07View SEC filing
10-Q · Filed 2025-05-08View SEC filing

Companies in the same industry

AAGH AARD ABBV ABCL ABEO ABT ABUS ABVC ACET ACRS ACRV ACTU

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.